Washington Trust’s Microbot Medical MBOT Stock Holding History

Washington Trust’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	–	–	945
2020 Q1	$0	Buy	+1	New	+$9	﹤0.01%	960

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Washington Trust's MBOT Position: Q2 2020 in Review

Washington Trust sold out of Microbot Medical (MBOT) in Q2 2020, closing a stake of 1 share.

Washington Trust first reported a position in MBOT in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 23 funds tracked by Wall St. Rank hold MBOT as of Q2 2020.

Washington Trust reported no remaining Microbot Medical position as of Q2 2020 after selling out during the quarter.
Washington Trust sold 1 Microbot Medical share in Q2 2020.
Washington Trust first reported a position in Microbot Medical in Q1 2020 and held it in 1 quarter.
Washington Trust's Microbot Medical position peaked at $0 in Q1 2020.
23 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2020.

Based on Washington Trust's 13F filing for Q2 2020, filed 4 Aug 2020.